Living with a noncancerous blood disorder can be exhausting
Semaglutide is a GLP-1 receptor agonist that primarily acts on receptors in the brain (appetite regulation), pancreas (insulin secretion), and gastrointestinal tract (gastric emptying)
The exception is when using very high, advanced doses of metabolic peptides, where a larger individual may need the upper end of the range
doi:10.1016/j.jaac.2024.05.023
Neurochem Int 61:444454 Soares JI, Da Costa C, Ferreira MH, Andrade PA, Maia GH, Lukoyanov NV (2019) Partial depletion of septohippocampal cholinergic cells reduces seizure susceptibility, but does not mitigate hippocampal neurodegeneration in the kainate model of epilepsy
Take the medication after eating a light snack to reduce its effect on your stomach